Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: An international collaboration

Nandini Moorthy, Elizabeth Roy, Vamsi Kurra, Margaret Peterson, Afton L. Hassett, Thomas Lehman, Christiaan Scott, Dalia El-Ghoneimy, Shereen Saad, Reem El Feky, Sulaiman Al-Mayouf, Pavla Dolezalova, Hana Malcova, Troels Herlin, Susan Nielsen, Nico Wulffraat, Annet Van Royen, Stephen D. Marks, Alexandre Belot, Jurgen BrunnerChristian Huemer, Ivan Foeldvari, Gerd Horneff, Traudel Saurenman, Silke Schroeder, Polyxeni Pratsidou-Gertsi, Maria Trachana, Yosef Uziel, Amita Aggarwal, Tamas Constantin, Rolando Cimaz, Theresa Giani, Luca Cantarini, Fernanda Falcini, Magni Manzoni, Angelo Ravelli, Donato Rigante, Fracnceso Zulian, Takako Miyamae, Shumpei Yokota, Juliana Sato, Claudia S. Magalhaes, Claudio A. Len, Simone Appenzeller, Oliveira Knupp, Cristine Rodrigues, Flavio Sztajnbok, Gasparello De Almeida, Almeida De Jesus, Maria De Arruda Campos, Clovis Silva, Calin Lazar, Gordana Susic, Tadej Avcin, Ruben Cuttica, Ruben Burgos-Vargas, Enrique Faugier, Jordi Anton, Consuelo Modesto, Liza Vazquez, Lilliana Barillas, Laura Barinstein, Gary Sterba, Irama Maldonado, Seza Ozen, Ozgur Kasapcopur, Erkan Demirkaya, Susa Benseler

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Background: Rheumatic diseases in children are associated with significant morbidity and poor health-related quality of life (HRQOL). There is no health-related quality of life (HRQOL) scale available specifically for children with less common rheumatic diseases. These diseases share several features with systemic lupus erythematosus (SLE) such as their chronic episodic nature, multi-systemic involvement, and the need for immunosuppressive medications. HRQOL scale developed for pediatric SLE will likely be applicable to children with systemic inflammatory diseases. Findings: We adapted Simple Measure of Impact of Lupus Erythematosus in Youngsters (SMILEY) to Simple Measure of Impact of Illness in Youngsters (SMILY-Illness) and had it reviewed by pediatric rheumatologists for its appropriateness and cultural suitability. We tested SMILY-Illness in patients with inflammatory rheumatic diseases and then translated it into 28 languages. Conclusion: SMILY-Illness is a brief, easy to administer and score HRQOL scale for children with systemic rheumatic diseases. It is suitable for use across different age groups and literacy levels. SMILY-Illness with its available translations may be used as useful adjuncts to clinical practice and research.
Lingua originaleEnglish
pagine (da-a)1-10
Numero di pagine10
RivistaPEDIATRIC RHEUMATOLOGY ONLINE JOURNAL
Volume12
DOI
Stato di pubblicazionePubblicato - 2014

Keywords

  • Adolescent
  • Antirheumatic Agents
  • Child
  • Child, Preschool
  • Feasibility Studies
  • Female
  • Humans
  • Immunosuppressive Agents
  • International Cooperation
  • Language
  • Male
  • Psychometrics
  • Quality of Life
  • Research Design
  • Rheumatic Diseases
  • Surveys and Questionnaires
  • Translating
  • Treatment Outcome

Fingerprint

Entra nei temi di ricerca di 'Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: An international collaboration'. Insieme formano una fingerprint unica.

Cita questo